Exagen director Ana Hooker resigns from board, committees effective immediately

• Exagen director Ana Hooker resigned from board and its committees effective April 17, 2026.
• Board size was cut to seven members from eight.
• Hooker’s resignation was not tied to any disagreement over operations, policies, or practices.
• Board committee leadership shifted, with Frank Stokes chairing Audit and Scott D. Kahn chairing Nominating and Corporate Governance.
• Charles McKhann was designated Compensation Committee chair.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exagen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001274737-26-000015), on April 23, 2026, and is solely responsible for the information contained therein.